XML 29 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated statements of cash flows - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash flows from (used in) operating activities [abstract]      
Profit (loss) before tax R$ 4,985,967 R$ 3,936,348 R$ 3,444,656
Adjustments to reconcile profit (loss) [abstract]      
Adjustments for depreciation expense 125,193 118,603 110,248
Adjustments for amortisation expense 140,132 133,810 95,629
Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss 29,452 32,266 20,805
Share of profit (loss) of associates and joint ventures accounted for using equity method (47,286) (73,507) 12,165
Gains (losses) on financial assets measured at fair value through other comprehensive income, net of tax 91,212 52,403 54,301
Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss, trade and other receivables 288,496 360,859 78,945
Adjustments for provisions 34,285 9,940 12,305
Adjustments for unrealised foreign exchange losses (gains) 1,188,410 (470,788) (301,697)
Adjustments for share-based payments 417,257 365,715 584,772
Adjustments for interest expense 609,375 637,640 429,222
Gains (losses) on disposals of investments 33,126 26,367 0
Changes In Assets And Liabilities [Abstract]      
Adjustments For Increase decrease In Securities (59,159,736) (12,743,703) (28,309,585)
Adjustments for decrease (increase) in derivative financial assets (7,340,657) 1,700,236 (1,550,061)
Adjustments for decrease (increase) in financial assets held for trading (2,057,519) 1,209,000 (1,423,398)
Adjustments for decrease (increase) in reverse repurchase agreements and cash collateral on securities borrowed (4,281,877) (4,495,605) 1,937,077
Adjustments for decrease (increase) in trade accounts receivable (109,731) (53,247) (157,056)
Adjustments for decrease (increase) in loans and advances to banks (951,004) (5,596,362) (9,416,502)
Adjustments for decrease (increase) in prepaid expenses 55,030 22,722 (257,357)
Adjustments for decrease (increase) in other assets (8,083,216) (437,106) (3,358,515)
Adjustments for increase (decrease) in repurchase agreements and cash collateral on securities lent 38,439,210 711,818 5,508,746
Adjustments for increase (decrease) in trade accounts payable (184,753) 326,344 (308,824)
Adjustments for increase (decrease) in deposits from banks 33,547,408 12,478,690 17,563,948
Adjustments For Increase decrease In Social And Statutory Obligations 164,784 126,692 (54,093)
Adjustments For Increase decrease In Tax And Social Security Obligations (154,910) 17,407 (91,326)
Adjustments for increase (decrease) in employee benefit liabilities 9,815,312 10,675,260 13,812,415
Adjustments for increase (decrease) in other liabilities 4,484,949 (347,790) 3,938,385
Cash flows from (used in) operations 12,078,909 8,724,012 2,375,205
Income taxes refund (paid) (542,404) (402,842) (370,862)
Contingencies Paid (8,188) (52,667) (2,521)
Interest paid (349,353) (141,202) (197,937)
Cash flows from (used in) operating activities 11,178,964 8,127,301 1,803,885
Cash flows from (used in) investing activities [abstract]      
Purchase of intangible assets (185,404) (130,219) (82,412)
Purchase of property, plant and equipment (144,808) (66,004) (44,563)
Disposal of property and equipment assets (10,000) 0 0
Cash flows used in obtaining control of subsidiaries or other businesses 0 770,887 (69,532)
Acquisition of associates (1,393,863) (65,444) (174,773)
Other cash payments to acquire interests in joint ventures, classified as investing activities 46,812 0 0
Losses on disposals of investments 0 29,589 0
Cash flows from (used in) investing activities (1,667,263) 538,809 (371,280)
Cash flows from (used in) financing activities [abstract]      
Proceeds from borrowings 0 2,252,550 0
Increase (decrease) through treasury share transactions, equity (1,353,611) (915,859) (1,814,823)
Proceeds from issue of bonds, notes and debentures 1,159,233 373,481 1,890,500
Repayments of borrowings (2,381,225) (1,966,674) (101,716)
Repayments of bonds, notes and debentures (1,170,612) (590,029) (175,999)
Dividends paid (2,037,082) (3,542,298) 0
Increase Decrease From Transactions With Non Controlling Interests (5) (4,146) 3,556
Dividends paid to non-controlling interests (991) (1,853) (1,820)
Cash flows from (used in) financing activities (5,784,293) (4,394,828) (200,302)
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes 3,727,408 4,271,282 1,232,303
Cash and cash equivalents at beginning of period 9,210,484 4,967,480 3,751,861
Effect of exchange rate changes on cash and cash equivalents (28,278) (28,278) (16,684)
Cash and cash equivalents at end of period 12,909,614 9,210,484 4,967,480
Cash 5,610,548 3,943,307 3,553,126
Reverse Repurchase Agreements And Cash Collateral On Securities Borrowed Included In Cash And Cash Equivalents 2,885,843 2,760,296 646,478
Short-term deposits, classified as cash equivalents 69,224 67,985 252,877
Other deposits R$ 4,343,999 R$ 2,438,896 R$ 514,999